These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6956734)

  • 21. Second-trimester pregnancy termination: comparison of three different methods.
    Makhlouf AM; Al-Hussaini TK; Habib DM; Makarem MH
    J Obstet Gynaecol; 2003 Jul; 23(4):407-11. PubMed ID: 12881083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dilatation and evacuation procedures and second-trimester abortions. The role of physician skill and hospital setting.
    Cates W; Schulz KF; Grimes DA; Horowitz AJ; Lyon FA; Kravitz FH; Frisch MJ
    JAMA; 1982 Aug; 248(5):559-63. PubMed ID: 6285012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of extrauterine fetal death with failure of prostaglandin E2 suppositories.
    Orr JW; Huddleston JF; Goldenberg RL; Knox GE; Davis RO
    Obstet Gynecol; 1979 Mar; 53(3 Suppl):56S-58S. PubMed ID: 424129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gameprost, sulproston and dinoproston for induced abortion in the 15th-24th week of pregnancy].
    Kamali P; Hohmann M; Herrero J; Künzel W
    Zentralbl Gynakol; 1998; 120(6):293-300. PubMed ID: 9659700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of two prostaglandins used to terminate midtrimester pregnancy.
    Gookin KS; White CK; Whitworth NS; Wiser WL; Morrison JC
    South Med J; 1984 Jun; 77(6):717-8, 721. PubMed ID: 6587588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Termination of pregnancy by extraamniotic prostaglandins and the synergistic action of oxytocin.
    Embrey MP; Hillier K; Mahendran P
    Adv Biosci; 1973; 9():507-13. PubMed ID: 4805861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complications of induced abortion.
    Hepburn S
    Fam Plann Inf Serv; 1981 Apr; 1(6):21-8. PubMed ID: 12263451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories.
    Southern EM; Gutknecht GD
    Obstet Gynecol; 1976 May; 47(5):602-6. PubMed ID: 1264407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morbidity and mortality from second-trimester abortions.
    Grimes DA; Schulz KF
    J Reprod Med; 1985 Jul; 30(7):505-14. PubMed ID: 3897528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extra-amniotic prostaglandin E2 for midtrimester termination of pregnancy in live fetuses vs. fetal demise.
    Debby A; Sagiv R; Girtler O; Sadan O; Glezerman M; Golan A
    Arch Gynecol Obstet; 2003 Oct; 268(4):301-3. PubMed ID: 14504874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Midtrimester dilation and evacuation versus prostaglandin induction: a comparison of composite outcomes.
    Whitley KA; Trinchere K; Prutsman W; Quiñones JN; Rochon ML
    Am J Obstet Gynecol; 2011 Oct; 205(4):386.e1-7. PubMed ID: 22083061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. World Health Organization studies of prostaglandins versus saline as abortifacients. A reappraisal.
    Cates W; Grimes DA; Schulz KF; Ory HW; Tyler CW
    Obstet Gynecol; 1978 Oct; 52(4):493-8. PubMed ID: 213748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second-trimester pregnancy termination for genetic abnormalities.
    Rayburn WF; LaFerla JJ
    J Reprod Med; 1982 Sep; 27(9):584-8. PubMed ID: 7143324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menstrual regulation with prostaglandin analogues.
    Hagenfeldt K; Bygdeman M
    Reproduccion; 1981; 5(3):195-201. PubMed ID: 7026317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dilation and evacuation for second-trimester genetic pregnancy termination.
    Shulman LP; Ling FW; Meyers CM; Shanklin DR; Simpson JL; Elias S
    Obstet Gynecol; 1990 Jun; 75(6):1037-40. PubMed ID: 2342729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induced second trimester abortion by extra-amniotic prostaglandin infusion in patients with a cesarean scar: is it safe?
    Shapira S; Goldberger S; Beyth Y; Fejgin MD
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):511-4. PubMed ID: 10376860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
    Kent DR; Goldstein AI; Linzey EM
    J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preabortion cervical dilatation with a low-dose prostaglandin suppository. A comparison of two analogs.
    Lauersen NH; Graves ZR
    J Reprod Med; 1984 Feb; 29(2):133-5. PubMed ID: 6708030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extra-amniotic prostaglandin E2 and intravenous oxytocin in termination of mid-trimester pregnancy and the management of missed abortion and hydatiform mole.
    Arshat H
    Med J Malaysia; 1977 Mar; 31(3):220-5. PubMed ID: 904515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical guidelines. Cervical preparation for surgical abortion from 20 to 24 weeks' gestation.
    Newmann S; Dalve-Endres A; Drey EA;
    Contraception; 2008 Apr; 77(4):308-14. PubMed ID: 18342657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.